Sponsor:
AgeneBio
Code:
NCT05986721
Conditions
Mild Cognitive Impairment
Prodromal Alzheimer's Disease
Eligibility Criteria
Sex: All
Age: 55 - 70+
Healthy Volunteers: Not accepted
Interventions
AGB101
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-19. This information was provided to ClinicalTrials.gov by AgeneBio on 2024-12-19.